|
NFATC2IP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.183100E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.027600E-02 |
| Normal-vs-Stage2 |
2.562700E-03 |
| Normal-vs-Stage3 |
4.449700E-04 |
| Normal-vs-Stage4 |
1.284760E-01 |
| Stage1-vs-Stage2 |
1.140230E-01 |
| Stage1-vs-Stage3 |
2.759600E-02 |
| Stage1-vs-Stage4 |
7.984000E-01 |
| Stage2-vs-Stage3 |
9.468800E-01 |
| Stage2-vs-Stage4 |
1.547410E-01 |
| Stage3-vs-Stage4 |
9.152000E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.203200E-03 |
| Normal-vs-AfricanAmerican |
5.677600E-02 |
| Normal-vs-Asian |
3.985200E-01 |
| Caucasian-vs-AfricanAmerican |
8.008800E-01 |
| Caucasian-vs-Asian |
1.644440E-01 |
| AfricanAmerican-vs-Asian |
2.478200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.426300E-02 |
| Normal-vs-Female |
2.377900E-03 |
| Male-vs-Female |
5.748200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.870400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.258340E-03 |
| Normal-vs-Age(61-80Yrs) |
3.860000E-03 |
| Normal-vs-Age(81-100Yrs) |
4.115900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.816400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.007800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.763830E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.217200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.176600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.906600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.358000E-02 |
| Classical-VS-Follicular |
2.40639999999903E-05 |
| Classical-VS-Other |
7.643200E-01 |
| Classical-VS-Normal |
7.976000E-02 |
| Tall-VS-Follicular |
4.945600E-01 |
| Tall-VS-Other |
4.218200E-01 |
| Tall-VS-Normal |
4.398800E-03 |
| Follicular-VS-Other |
2.704400E-01 |
| Follicular-VS-Normal |
1.97570999999064E-05 |
| Other-VS-Normal |
3.485000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.985400E-04 |
| Normal-vs-N1 |
2.517400E-01 |
| N0-vs-N1 |
5.852000E-02 |
|
|
